TY - CHAP M1 - Book, Section TI - Secondary Amenorrhea & Menopause A1 - Fitzgerald, Paul A. A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. PY - 2021 T2 - Current Medical Diagnosis & Treatment 2021 AB - Key Clinical Updates in Secondary Amenorrhea & MenopauseParoxetine is FDA-approved for treatment of vasomotor symptoms but it is not recommended for women taking tamoxifen, since it reduces the conversion of tamoxifen to its active metabolite. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2023/02/06 UR - accessmedicine.mhmedical.com/content.aspx?aid=1175787153 ER -